Yes. Thousands of lawsuits alleging injuries from implanted port catheters have been consolidated in federal court under MDL No. 3081, formally titled In re Bard Implanted Port Catheter Products Liability Litigation. The case is being heard in the U.S. District Court for the District of Arizona under Senior U.S. District Judge David G. Campbell.
The defendants include Becton Dickinson, C. R. Bard, Bard Access Systems, and related entities. The cases center on several Bard implantable port systems, particularly the PowerPort, PowerPort ClearVUE, and PowerPort MRI. Plaintiffs say these devices share design problems that make them likely to fracture inside the body, move from their original placement, and shed fragments into the bloodstream, causing complications that can be serious or life-threatening.
Consolidating these cases into an MDL lets the court coordinate pretrial proceedings, share discovery across cases, and handle common questions about device design, safety testing, and manufacturer warnings far more efficiently than individual cases would allow. Courts are now examining internal documents, adverse event reports, and communications about known risks as the litigation advances. The cases may resolve through individual settlements, a global program, or trials.
No other port catheter litigation currently comes close to the scale or procedural development of MDL 3081, making it the central legal proceeding for individuals harmed by Bard implantable port systems.
You may have a viable claim in MDL 3081 if you suffered complications from a Bard PowerPort or another implanted port catheter system. With over 35 years of experience reviewing defective medical device cases, our team can assess your records and let you know where you stand. Reach out to Atraxia Law for a free, no-obligation case evaluation.